Michael G Dwyer, Niels Bergsland, Alexander Bartnik, Dejan Jakimovski, Samantha Noteboom, Menno M Schoonheim, Martijn D Steenwijk, Jinglan Pei, David Clayton, Robert Zivadinov
{"title":"Quantifying cortical lesions in multiple sclerosis MRI datasets using multi-contrast post-processing and deep learning.","authors":"Michael G Dwyer, Niels Bergsland, Alexander Bartnik, Dejan Jakimovski, Samantha Noteboom, Menno M Schoonheim, Martijn D Steenwijk, Jinglan Pei, David Clayton, Robert Zivadinov","doi":"10.1038/s43856-026-01683-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Multiple sclerosis (MS) is a chronic neurological disease affecting both white and gray matter of the central nervous system. Despite the well-established involvement of cortical lesions in MS, feasibility limitations in their visualization on typical magnetic resonance imaging (MRI) protocols prevent their evaluation in nearly all clinical trials. Recently, several post-processing methods, including synthetic contrasts and artificial intelligence (AI)-based approaches, have shown potential for enhancing cortical lesion detection on conventional MRI data. These methods have the potential to reanalyze existing clinical-trial data to answer key mechanistic questions about both MS development and about treatment effects.</p><p><strong>Methods: </strong>We sought to evaluate the feasibility of combining and extending existing methods into a unified framework for analysis using the data from the large, multicenter, phase 3 ORATORIO trial (full n = 732, age=44.6 ± 8.0; development subset n = 80, age=46.6 ± 7.1). We specifically evaluated three of the most promising of them - fluid-attenuated inversion recovery squared (FLAIR<sup>2</sup>), T1/T2 ratio, and artificial intelligence-derived double inversion recovery (AI-DIR) - and introduced a new combined contrast called multi-modal cortical lesion enhanced (MMCLE). We also harnessed transformer-based semantic segmentation to improve automated detection and delineation of these lesions.</p><p><strong>Results: </strong>At baseline, we detected 14.8 + /-20.72 lesions per participant, with 86.0% true positive rate and 8.4% false positive rate across subjects for blinded MMCLE, using simultaneous review of all contrasts as the reference. High reproducibility was observed across field strengths and acquisition types (ICC 88.8-92.5%).</p><p><strong>Conclusions: </strong>We confirmed that cortical lesions can be clearly visualized and quantified with these methods. Using deep learning, we also confirmed that the simultaneous use of multiple contrasts improves quantification.</p>","PeriodicalId":72646,"journal":{"name":"Communications medicine","volume":"6 1","pages":""},"PeriodicalIF":7.4000,"publicationDate":"2026-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13342072/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Communications medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1038/s43856-026-01683-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Multiple sclerosis (MS) is a chronic neurological disease affecting both white and gray matter of the central nervous system. Despite the well-established involvement of cortical lesions in MS, feasibility limitations in their visualization on typical magnetic resonance imaging (MRI) protocols prevent their evaluation in nearly all clinical trials. Recently, several post-processing methods, including synthetic contrasts and artificial intelligence (AI)-based approaches, have shown potential for enhancing cortical lesion detection on conventional MRI data. These methods have the potential to reanalyze existing clinical-trial data to answer key mechanistic questions about both MS development and about treatment effects.
Methods: We sought to evaluate the feasibility of combining and extending existing methods into a unified framework for analysis using the data from the large, multicenter, phase 3 ORATORIO trial (full n = 732, age=44.6 ± 8.0; development subset n = 80, age=46.6 ± 7.1). We specifically evaluated three of the most promising of them - fluid-attenuated inversion recovery squared (FLAIR2), T1/T2 ratio, and artificial intelligence-derived double inversion recovery (AI-DIR) - and introduced a new combined contrast called multi-modal cortical lesion enhanced (MMCLE). We also harnessed transformer-based semantic segmentation to improve automated detection and delineation of these lesions.
Results: At baseline, we detected 14.8 + /-20.72 lesions per participant, with 86.0% true positive rate and 8.4% false positive rate across subjects for blinded MMCLE, using simultaneous review of all contrasts as the reference. High reproducibility was observed across field strengths and acquisition types (ICC 88.8-92.5%).
Conclusions: We confirmed that cortical lesions can be clearly visualized and quantified with these methods. Using deep learning, we also confirmed that the simultaneous use of multiple contrasts improves quantification.